Algocare
Practice tests Home All programs

Steroidal Anti-Inflammatory Drugs

Introduction to Corticosteroids and Mechanism of Action

Corticosteroids are powerful anti-inflammatory and immunosuppressive agents synthesized to mimic cortisol, a hormone naturally produced by the adrenal cortex. They enter target cells and bind to specific intracellular glucocorticoid receptors. This hormone-receptor complex moves into the cell nucleus, where it binds to DNA and alters gene transcription.

At the cellular level, corticosteroids stimulate the production of lipocortin-1, an inhibitor of the enzyme phospholipase A2. Blocking phospholipase A2 stops the release of arachidonic acid from cell membranes, effectively shutting down both the cyclooxygenase (COX) and lipoxygenase pathways. Consequently, the body stops producing inflammatory mediators like prostaglandins and leukotrienes.

Beyond blocking chemical mediators, these drugs suppress the immune system by reducing the proliferation, differentiation, and function of T-lymphocytes, B-lymphocytes, and macrophages. They also stabilize lysosomal membranes, preventing the release of proteolytic enzymes that worsen tissue destruction at injury sites.

Classification and Potency of Steroidal Anti-Inflammatory Drugs

Steroids are classified based on their duration of action and relative anti-inflammatory potency compared to hydrocortisone. Clinical selection depends on the desired speed of onset and whether the therapy is short-term or long-term.

Pharmacokinetics and Administration Routes

Corticosteroids are well absorbed through the gastrointestinal tract when given orally. They bind extensively to plasma proteins, primarily transcortin (corticosteroid-binding globulin) and albumin. Hepatic metabolism transforms them into inactive water-soluble metabolites, which the kidneys then excrete.

The choice of administration route dictates the speed and localization of the therapeutic response:

  1. Oral: Preferred for chronic maintenance therapy due to ease of administration.
  2. Intravenous: Used in life-threatening emergencies, severe allergic reactions, or acute exacerbations of autoimmune diseases.
  3. Intramuscular: Provides sustained systemic absorption when oral administration is impractical.
  4. Topical and Inhaled: Deliver high local concentrations directly to target tissues like the skin or lungs, minimizing systemic absorption and associated adverse effects.
  5. Intra-articular: Injected directly into joint spaces to relieve localized inflammation and pain.

Therapeutic Indications in Clinical Practice

Corticosteroids manage a vast array of conditions characterized by excessive or unwanted inflammation and immune activity. They are not curative; instead, they control symptoms while the underlying disease runs its course or enters remission.

SystemClinical IndicationPrimary Purpose
MusculoskeletalRheumatoid arthritis, systemic lupus erythematosusSuppress joint inflammation and tissue destruction
RespiratoryAsthma exacerbations, chronic obstructive pulmonary diseaseReduce bronchial edema and airway hyperreactivity
HematologicAutoimmune hemolytic anemia, acute leukemiaDecrease destruction of blood cells or suppress malignancy
DermatologicSevere contact dermatitis, pemphigusControl painful, blistering skin lesions
EndocrinePrimary and secondary adrenal insufficiencyProvide necessary physiological hormone replacement

Adverse Effects of Corticosteroid Therapy

Long-term or high-dose corticosteroid therapy affects nearly every organ system. Nurses must anticipate these side effects to provide proactive patient care.

Contraindications, Precautions, and Drug Interactions

Before initiating corticosteroid therapy, clinicians must evaluate pre-existing conditions that could worsen with treatment. Systemic fungal infections, active untreated tuberculosis, and certain viral infections represent absolute contraindications because the drug-induced immunosuppression allows pathogens to spread unchecked.

Precautions are necessary for patients with hypertension, heart failure, diabetes mellitus, osteoporosis, or a history of peptic ulcer disease.

Concomitant drug therapy introduces significant interaction risks:

HPA Axis Suppression and Safe Tapering Protocols

The hypothalamus-pituitary-adrenal (HPA) axis relies on a negative feedback loop. When exogenous corticosteroids circulate in high amounts, the hypothalamus stops producing corticotropin-releasing hormone (CRH), and the pituitary gland halts adrenocorticotropic hormone (ACTH) secretion. Without internal ACTH stimulation, the adrenal cortex undergoes functional atrophy.

If systemic steroids are stopped abruptly, the atrophied adrenal glands cannot immediately resume endogenous cortisol production. This results in acute adrenal crisis, characterized by profound fatigue, hypotension, hypoglycemia, circulatory collapse, and shock.

To prevent this, patients undergoing therapy lasting longer than two weeks must have their dosage gradually tapered. Tapering allows the HPA axis time to recover normal function and endogenous hormone synthesis.

Nursing Responsibilities and Patient Education

Comprehensive nursing care involves monitoring clinical parameters, administering medications safely, and educating patients to manage chronic therapy successfully.

Nurses must monitor baseline and ongoing weight, blood pressure, serum glucose levels, and electrolyte panels. Assessment for hidden signs of infection is critical since the anti-inflammatory action masks typical inflammatory responses like fever, redness, and swelling.

Patient education focuses on safe medication habits:

Test yourself on this topic →
Privacy Policy Terms & Disclaimer